Shopping Cart 0
Cart Subtotal
USD 0

Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Nipro Corp (8086)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company's products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, half-type kits among others. It also offers contract manufacturing services of injection, oral and external use drug formulations. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia, and Africa. Nipro is headquartered in Osaka, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Nipro Corp-Key Facts 6

Nipro Corp-Key Employees 7

Nipro Corp-Major Products and Services 8

Nipro Corp-History 11

Nipro Corp-Company Statement 13

Nipro Corp-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Joint Venture 16

Section 2-Company Analysis 17

Company Overview 17

Nipro Corp-Business Description 18

Business Segment: Medical-Related segment 18

Overview 18

Performance 18

Business Segment: Other segment 18

Overview 18

Performance 18

Business Segment: Pharma Packaging segment 18

Overview 18

Performance 18

Business Segment: Pharmaceutical-Related segment 19

Overview 19

Performance 19

Geographical Segment: America 19

Performance 19

Geographical Segment: Asia 19

Performance 19

Geographical Segment: Europe 19

Performance 19

Geographical Segment: Japan 19

Performance 19

R&D Overview 19

Nipro Corp-Corporate Strategy 20

Nipro Corp-SWOT Analysis 21

SWOT Analysis-Overview 21

Nipro Corp-Strengths 21

Nipro Corp-Weaknesses 22

Nipro Corp-Opportunities 23

Nipro Corp-Threats 24

Nipro Corp-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

Nipro Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 33

Nipro Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 34

Nipro Corp, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

Feb 02, 2017: SMT appoints EUKON as strategic partner in Italy 36

Section 6-Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41


List Of Figure

List of Figures

Nipro Corp, Performance Chart (2014-2018) 30

Nipro Corp, Ratio Charts 32

Nipro Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 33

Nipro Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 34


List Of Table

List of Tables

Nipro Corp, Key Facts 6

Nipro Corp, Key Employees 7

Nipro Corp, Major Products and Services 8

Nipro Corp, History 11

Nipro Corp, Other Locations 14

Nipro Corp, Subsidiaries 14

Nipro Corp, Joint Venture 16

Nipro Corp, Key Competitors 25

Nipro Corp, Ratios based on current share price 26

Nipro Corp, Annual Ratios 27

Nipro Corp, Annual Ratios (Cont...1) 28

Nipro Corp, Annual Ratios (Cont...2) 29

Nipro Corp, Interim Ratios 31

Nipro Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 33

Nipro Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 34

Nipro Corp, Recent Deals Summary 35

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Nipro Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Terumo Corp

Taiho Pharmaceutical Co Ltd

Mitsubishi Tanabe Pharma Corp

Kyowa Hakko Kirin Co Ltd

Fresenius SE & Co KGaA

Chugai Pharmaceutical Co Ltd

B. Braun Melsungen AG

Asahi Kasei Medical Co Ltd